Genetron Highlights New Minimal Residual Disease Data, Sets Plans for Solid Tumor Testing in China
360Dx,
NEW YORK – Genetron Health is anticipating significant milestones for its solid tumor minimal residual disease (MRD) technology…
NEW YORK – Genetron Health is anticipating significant milestones for its solid tumor minimal residual disease (MRD) technology…
NEW YORK – Genetron Health is anticipating significant milestones for its solid tumor minimal residual disease (MRD) technology…